Introduction
Macular Diseases
Subliminal laser therapy: a macular treatment

There remains an unmet need in the treatment of macular diseases. Increasing evidence demonstrates SubLiminal laser therapy to be safe and effective for macular conditions such as DME and CSC.

A macular treatment

Treatment guidelines

Testimonials

Clinical data
Peripheral Retinal Diseases
Subliminal laser therapy: not a peripheral treatment

Several studies demonstrate that retinal destruction was required to control the neovascularization process in PDR. For peripheral conditions Multispot laser photocoagulation should be favored.

Multispot for PRP treatment

Treatment guidelines

Testimonials

Clinical data
Media Library

Archives: Vidéos

Expanding clinical application of SubLiminal laser

20/09/2019

Discover this video in which Dr Victor Chong talks about the expanding clinical application of SubLiminal laser during EURETINA 2019.

SubLiminal laser for cCSC management

20/09/2019

Lebriz Altay presenting SubLiminal laser for cCSC management at EURETINA 2019.

Yellow subthreshold laser vs pdt in eyes with CCSC

20/09/2019

Lihteh Wu presenting yellow subthreshold laser advantages versus PDT in eyes with CCSC at EURETINA 2019.

Subliminal laser for the treatment of Central Serous Chorioretinopathy

07/09/2019

Paula Scholz, M.D., FEBO, explains step by step, with her own experience, why subliminal laser therapy is an ideal treatment for Central Serous Chorioretinopathy.

Fovea-Involving DME: Reasons for the subliminal approach

07/09/2019

During EURETINA 2019, Alejandro Filloy Rius, MD Ph.D, talks about fovea involving DME and the reasons for the subliminal approach

SubLiminal Laser therapy

25/09/2018

Dr. Paula Scholz talks about SubLiminal laser therapy.

Treatment guidelines – Paula Scholz – Meeting Londres 2018

24/09/2018

Find out more about Subliminal treatment guidelines with Dr Paula Scholz.

Efficacy of SubLiminal laser in IPCV Aflibercept resistant cases

20/09/2018

During EURETINA 2018, Saad Younis makes a presentation on the safety and efficacy of SubLiminal Laser in Patients with Idiopathic Polypoidal Chroidal Vasculopathy Aflibercept resistant cases.

Our first year of lessons learnt with SubLiminal laser for CCSC and DME

20/09/2018

Alejandro Filloy Rius, MD Ph.D, explains the first year of lessons learnt with SubLiminal laser for CCSC and DME at EURETINA 2018.

Why consider the yellow 577nm wavelength?

05/12/2016

Giovanni Staurenghi, MD, explains why yellow 577nm laser is the wavelength of choice for retina treatments.

Quantel Medical & Ellex, 2 brands of Lumibird Medical, united with 1 objective: develop cutting-edge technologies for the diagnosis and treatment of dry eye and leading causes of blindness worldwide: glaucoma, cataracts, AMD and diabetic retinopathy.

More info

Subthreshold Ophthalmic Laser Society

"*" indicates required fields

Name

First Last

The information collected through this form is recorded and transmitted to the relevant QUANTEL MEDICAL departments and enables us to send you any reply to a request via the contact form. The legal basis for the processing is consent. The data collected are kept for 3 years in digital format and are only transmitted to QUANTEL MEDICAL’s internal departments as well as to our distributors and subsidiaries. You have a right to access, rectify, contest, limit the processing of and erase data. For more information on the use of your data and your rights resulting from the amended French Data Protection Act and the GDPR, please consult our data protection policy or contact our Data Protection Officer at privacy@lumibird.com.

Country*

Personal data compliance

I agree to my personal data being used by QUANTEL MEDICAL to send me marketing information about QUANTEL MEDICAL’s new products, events or offers (mailings).

I do not agree to my personal data being used by QUANTEL MEDICAL to send me marketing information about QUANTEL MEDICAL’s new products, events or offers (mailings).

Email*

For more informations on how Quantel Medical uses your data, please see our Terms and conditions.

Data policy

Site plan – Terms & Conditions – Privacy policy – Cookie policy

Archives: Vidéos

Expanding clinical application of SubLiminal laser

SubLiminal laser for cCSC management

Yellow subthreshold laser vs pdt in eyes with CCSC

Subliminal laser for the treatment of Central Serous Chorioretinopathy

Fovea-Involving DME: Reasons for the subliminal approach

SubLiminal Laser therapy

Treatment guidelines – Paula Scholz – Meeting Londres 2018

Efficacy of SubLiminal laser in IPCV Aflibercept resistant cases

Our first year of lessons learnt with SubLiminal laser for CCSC and DME

Why consider the yellow 577nm wavelength?

More info

Newsletter